Biotechnology News

Biotech

Wis. Mulls Harley-Davidson, Cheese Microbe Honors

Choppers and Cheese: Wisconsin state honors sought for Harley-Davidson, cheese microbe

11/20/09 - 03:08 PM EST

Stem-cell Debate Unlikely To Fade After Neb. Vote

Latest U. of Nebraska debate over embryonic stem-cell research shows dispute unlikely to fade

11/20/09 - 06:39 AM EST

Try Jim Cramer's Action Alerts PLUS
Novavax Plans Offering Of 6.8M Shares; Stock Falls
  • Tickers in this article:
  • NVAX

Drug developer Novavax to offer 6.8 million shares of common stock at $3.30 each; stock falls

11/20/09 - 10:36 AM EST

Article

Biotech Stock Mailbag: FDA Playbook

Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.

11/20/09 - 06:01 AM EST

Article

Vaccines On Horizon For AIDS, Alzheimer's, Herpes

'Golden era' could bring vaccines against AIDS, Alzheimer's and addictions within 5 years

11/17/09 - 01:48 PM EST

Article

Judges: Seattle Biotech Can Pursue $23M Claim

  • Tickers in this article:
  • CTIC

Federal appeals court: Seattle biotech can pursue $23 million claim against former consultant

11/18/09 - 08:08 PM EST

Article

U.S. Sees Low Demand for BioCryst Flu Drug

  • Tickers in this article:
  • BCRX
  • GSK

Peaking flu season could mean no need for further peramivir orders.

11/18/09 - 11:12 AM EST

Article

Another Genzyme Drug Goes Kaboom: BioBuzz

Company halts development of kidney disease drug following poor test results.

11/18/09 - 08:05 AM EST

Article

Vivus Seeks Faster ED Drug: Biobuzz

Company says ED drug met all goals in phase III study.

11/18/09 - 06:42 AM EST

Video

Trading Higher in a Down Market

NEW YORK (TheStreet) -- Portfolio Manager David Peltier discusses two low-dollar stocks that are bucking the market trend on Tuesday.

11/17/09 - 01:15 PM EST

Article

Genzyme's Termeer: Worst Biotech CEO of '09

Genzyme CEO Henri Termeer is Adam Feuerstein's Worst Biotech CEO of the Year for 2009.

11/17/09 - 12:31 PM EST

Article

Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz

Mipomersen lowers cholesterol but not without liver side effects.

11/17/09 - 10:56 AM EST

Article

InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzz

Safety monitors force change to mid-stage study of ITMN-191

11/17/09 - 09:11 AM EST

Article

Vical Will Be Added To Biotech Index, Shares Rise

  • Tickers in this article:
  • VICL

Vical shares rise after the company says it will be listed on Nasdaq biotech index Nov. 23

11/16/09 - 02:27 PM EST

Dow Jones S&P 500 NASDAQ 10-Year Note
10,318.16 1,091.38 2,146.04 33.56
Oil *
77.53
DOWN
14.28
DOWN
3.52
DOWN
10.78
UP
0.07
10 Yr
3.36%
SPDR Gold
112.94
-0.14%
-0.32%
-0.50%
+0.21%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services